GeM

Active

Goods

Nebulizer (V2)

PRODUCT

Converts to RA

Nebulizer (V2) (Q2)

Indian Army

Pune, Maharashtra

Amount: Refer DocsCloses: 10 Sept 2026

Timeline

Published20 Aug 2026
Closes10 Sept 2026
Bid Opening10 Sept 2026

Tender Value

Refer Docs

EMD Value

Exempted

Closing Date

10 Sept 2026, 10:00 am

Work Description

Nebulizer (V2) (Q2)

Tender Information

Tender ID

9743811

Reference Number

GEM/2026/B/7906833

Tender Type

Two Packet Bid

Product Category

Nebulizer (V2)

Location

Pune, Maharashtra

Evaluation Method

Total value wise evaluation

Bid Type

PRODUCT

Source Website

Subscribe to view

Documents Required

7 documents required · 7 mandatory

RequiredExperience Criteria

RequiredPast Performance

RequiredBidder Turnover

RequiredCertificate (Requested in ATC)

RequiredOEM Authorization Certificate

RequiredOEM Annual Turnover

RequiredCompliance of BoQ specification and supporting document

Eligibility Criteria

Experience

2 yrs

Min Turnover

₹31

OEM Turnover

₹1 L

Past Performance

60%

Purchase Preferences

MSE Purchase PreferenceMSE EMD ExemptionMII Purchase PreferenceStartup Exemption

Items & Quantities

Item	Delivery Location	Qty	Delivery
Nebulizer (V2) (Q2)	PUNE CITY	6	30 days

Total: 6

Fee & Financial Details

EMD Fee Amount

Exempted

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

20 Aug 2026

Published

20 Aug 2026

Bid Opening

10 Sept 2026

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Documents

bid_9743811.pdf

GEM_BID • 0.13 MB

Additional Documents

ATC_16707066-6a54-42c2-b7eb1786513304017_inovationproc@gov.in.pdf

GEM_OTHER • 4.20 MB

gtc.pdf

GEM_OTHER • 0.71 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].